Related Experiment Videos
Hypothalamic-pituitary-adrenal axis interaction with prostaglandins.
M Thorén1, C Stenfors, B Apéria
1Karolinska Institute, Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1990
Summary
Short-term decreases in cortisol levels, induced by metyrapone or dexamethasone, significantly increase prostaglandin E2 (PGE2) metabolite levels (PGEM). This suggests cortisol suppression may stimulate prostaglandin synthesis.
Area of Science:
- Endocrinology
- Neuroscience
- Biochemistry
Background:
- Prostaglandin E2 (PGE2) is a key mediator in various physiological processes.
- The hypothalamic-pituitary-adrenal (HPA) axis regulates cortisol production.
- The interplay between HPA axis function and prostaglandin synthesis remains incompletely understood.
Purpose of the Study:
- To investigate the effect of short-term changes in HPA axis function on plasma PGE2 metabolite levels in humans.
- To determine if cortisol suppression influences prostaglandin synthesis.
Main Methods:
- Plasma 15-keto-13,14-dihydro-PGE (PGEM), serum cortisol, and serum 11-deoxycortisol were measured using radioimmunoassay (RIA).
- Participants underwent metyrapone tests (oral administration), dexamethasone suppression tests, and ACTH stimulation tests.
- Blood samples were collected at various time points before and after drug/hormone administration.
Main Results:
- Plasma PGEM levels significantly increased following metyrapone administration, coinciding with decreased serum cortisol.
- A significant increase in plasma PGEM was observed after dexamethasone-induced cortisol suppression.
- No difference in PGEM increase was noted between patients with normal or subnormal 11-deoxycortisol responses to metyrapone.
Conclusions:
- Short-term decreases in cortisol levels may stimulate prostaglandin synthesis.
- These findings suggest a potential regulatory link between glucocorticoid levels and eicosanoid production.